文献速递睡眠呼吸障碍咽喉与嗓音小儿耳鼻咽喉

阻塞性睡眠呼吸暂停临床试验的趋势与未来机遇

Clinical Trials in Obstructive Sleep Apnea: Recognizing Trends and Future Opportunities.
PubMed 文献 · Laryngoscope · 2018-10-03

该研究回顾性分析了1999至2017年ClinicalTrials.gov上813项阻塞性睡眠呼吸暂停(OSA)临床试验,描述了研究者特征、干预措施、资助来源和地域分布;持续气道正压通气(CPAP)试验占43.7%,药物治疗占19.2%,手术占10.7%;耳鼻咽喉科研究者仅占9.2%,睡眠外科在整体临床试验中声音较小。

要点

  • OSA临床试验以CPAP(43.7%)和药物(19.2%)为主,手术仅占10.7%。
  • 手术试验更可能由男性PI主持并涉及儿童患者(P < .001)。
  • 耳鼻咽喉科PI占9.2%,NIH资助率与其他专科无显著差异(P = .22)。

核心结论

  • 睡眠外科尤其是耳鼻咽喉科在OSA临床试验整体格局中占比较小。
  • 该分析可帮助指导未来研究方向并为本专科设定研究资助优先级。

研究设计与样本

  • 回顾性数据库综述,利用ClinicalTrials.gov评估1999至2017年813项OSA临床试验。
  • 收集首席研究者(PI)人口学、研究干预、资助来源和研究机构地域分布信息。

主要发现

  • CPAP干预试验占43.7%,药物治疗占19.2%,手术干预占10.7%(n = 87)。
  • 59.9%的研究基于国际;PI以男性为主(72.0%),72.7%拥有MD学位,28.6%拥有PhD学位。
  • 手术与非手术研究在资助来源(NIH vs. 工业界,P = .14)或机构地域(国际 vs. 美国,P = .73)上无显著差异。
  • 手术试验相比非手术试验更可能由男性PI主持并涉及儿童患者(P < .001)。
  • 耳鼻咽喉科医生占所有PI的9.2%,其NIH资助率与其他医学专科相似(P = .22)。

临床怎么用

  • 了解OSA临床试验的分布有助于耳鼻咽喉科医生识别研究空白并调整研究方向。
  • 鼓励本专科在设定研究资助优先级时参考这些趋势,并推动跨学科研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: Examine US and international clinical trials in obstructive sleep apnea (OSA) to characterize researchers involved, interventions being studied, and opportunities for future investigation. STUDY DESIGN: Retrospective database review. METHODS: The information from ClinicalTrials.gov was used to assess OSA clinical trials between 1999 and 2017. Information was gathered on principle investigator (PI) demographics, interventions studied, study funding source, and regional distribution of research institutions. RESULTS: There were 813 clinical trials studied. The majority of trials examined continuous positive airway pressure interventions (43.7%), with pharmacotherapies being the second most commonly investigated treatment (19.2%). Surgical interventions made up 10.7% (n = 87) of clinical trials for OSA. Most studies were based internationally (59.9%). PIs were predominantly male (72.0%); 72.7% had an MD and 28.6% had a PhD. There were no significant differences in funding source (National Institutes of Health vs. industry, P = .14) or institutional geography (international vs. US, P = .73) between surgical and nonsurgical studies. Surgical trials were significantly more likely to have a male PI and involve pediatric patients compared to nonsurgical trials (P < .001). Otolaryngologists represented 9.2% of all PIs and had similar rates of NIH funding compared to other medical specialists (P = .22). CONCLUSIONS: This study provides a broad overview of past, current, and future treatment paradigms for OSA. Sleep surgery, specifically otolaryngology, is a small voice in the overall landscape of clinical trials for OSA. This information can help guide future research efforts and direct our specialty when setting priorities regarding research funding while encouraging a broad and interdisciplinary pursuit. LEVEL OF EVIDENCE: NA Laryngoscope, 129:1940-1944, 2019.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Singh SK, Gu D, Capasso R, et al. Clinical Trials in Obstructive Sleep Apnea: Recognizing Trends and Future Opportunities. Laryngoscope. 2018. PMID: 30284271. doi:10.1002/lary.27453

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。